Lymph node metastasis from breast cancer diagnosed by F-18 FDG whole-body PET (case report)

被引：2
作者：
Fujii H. [1 ,3 ]
Enomoto K. [2 ]
Ikeda T. [2 ]
Hojo T. [2 ]
Yasuda S. [3 ]
Ide M. [3 ]
Shohtsu A. [3 ]
Kameyama K. [4 ]
Kubo A. [1 ]
机构：
[1] Department of Radiology, Keio University, School of Medicine, Shinjuku-ku, Tokyo 160-8582
[2] Division of Diagnostic Pathology, Keio University, School of Medicine
来源：
Breast Cancer | 2000年 / 7卷 / 2期
关键词：
Breast cancer; F-18 fluorodeoxyglucose (FDG); Lymph node metastasis; Positron Emission Tomography (PET);
D O I：
10.1007/BF02967451
中图分类号：
学科分类号：
摘要：
We report a 48-year-old woman with lymph node (LN) metastases from breast cancer in whom diagnosis was difficult by conventional imaging methods but easy by F-18 fluorodeoxyglucose (FDG) PET. She was given a diagnosis of right breast cancer and then unde~ent modified radical mastectomy in December 1997. During routine CT and US studies in September 1998, a questionable LN measuring 1 cm in diameter was detected in the right supraclavicular region, but a definitive diagnosis of this LN was difficult by these tests. The patient underwent FDG PET test, which showed strong nodular activity (SUV= 7.1) in the right supraclavicular region, indicating a metastatic lesion. Moreover, an unexpected second metastatic LN lesion (SUV=5.5) in the medial aspect of the right axillary was diagnosed by PET. The PET results were confirmed by pathological examination of the surgical specimens. FDG PET is a useful tool to detect small malignant lesions that are not easily diagnosed by conventional imaging techniques such as CT and US. It is expected that PET test will be feasible at many institutions.
引用
收藏
页码：165 / 168
页数：3
相关论文
共 21 条
  • [1] Recht A., Hayes D.F., Eberlein T.J., Et al., Local-regional recurrence after mastectomy or breast-conserving therapy, Disease of the Breast, pp. 649-667, (1996)
  • [2] Yunoki M., Kunimatsu N., Kohno A., Axilla, pectoral and internal mammary lymph nodes, Clin Imagiol, 14, pp. 1076-1082, (1998)
  • [3] Wahl R.L., Cody R.L., Hutchins G.D., Et al., Primary and metastatic breast carcinoma
  • [4] Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose, Radiology, 179, pp. 765-770, (1991)
  • [5] Adler L.P., Crowe J.P., Al-Kaisi N.K., Sunshine J.L., Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy- 2-fluoro-D-glucose PET, Radiology, 187, 3, pp. 743-750, (1993)
  • [6] General Rules for Clinical and Pathological Recording of Breast Cancer, 13th Ed, pp. 1-56, (1998)
  • [7] Avril N., Bense S., Ziegler S.I., Dose J., Weber W., Laubenbacher C., Romer W., Janicke F., Schwaiger M., Breast imaging with fluorine-18-FDG PET: Quantitative image analysis, Journal of Nuclear Medicine, 38, 8, pp. 1186-1191, (1997)
  • [8] Konishi Y., Hashimoto T., Okuno T., Et al., Preoperative diagnosis of internal mammary node metastases in patients with breast cancer by using ultrasonography, Nippon Geka Gakkai Zasshi, 93, pp. 1330-1336, (1992)
  • [9] Ogawa Y., Nishioka A., Hata Y., Et al., Helical CT of breast cancer, Clinical Imagiol, 13, pp. 431-442, (1997)
  • [10] Warburg O., On the origin of cancer cells, Science, 123, pp. 309-314, (1956)
123